What is VLST?
VLST Corporation is a privately held biotechnology company focused on the discovery and development of novel therapeutics for cancer, inflammatory, and autoimmune disorders. The company leverages a unique approach that combines advanced bioinformatics with cutting-edge proteomics to rapidly identify new therapeutic targets. This platform is designed for the efficient development of biologic therapies, aiming to address unmet medical needs in oncology and immunology.
How much funding has VLST raised?
VLST has raised a total of $5M across 1 funding round:
Unspecified
$5M
Unspecified (2012): $5M, investors not publicly disclosed
What's next for VLST?
With the recent infusion of $5M in strategic capital, VLST is poised for accelerated growth and development. This enterprise-level backing suggests a strong validation of the company's innovative approach to drug discovery. The financing is anticipated to fuel further research and development initiatives, potentially expanding the company's pipeline and advancing existing therapeutic candidates through clinical stages. VLST's focus on combining bioinformatics and proteomics positions it to make significant contributions to the treatment of complex diseases.
See full VLST company page
